Información del artículo
Artículo
Opciones para acceder a los textos completos de la publicación Cirugía Española
Suscriptor
Comprar
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
J.R. Siewert, A.H. Hölscher, K. Becker, W. Gössner.
Kardiacarcinom: Versuch einer therapeutisch relevanten Klassifikation [Cardia cancer: attempt at a therapeutically relevant classification].
Chirurg., 58 (1987), pp. 25-32
[2]
M. Nakauchi, H.S. Walch, S. Nussenzweig, et al.
Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on From the Siewert Classification.
Ann Surg., 281 (2025), pp. 989-996
[3]
V. Munitiz, A. Ortiz, D. Ruiz de Angulo, F.L. Martinez de Haro, P. Parrilla.
Results of the different surgical options for the treatment of cancer of the esophagogastric junction: Review of the evidence.
Cir Esp (Engl Ed)., 97 (2019), pp. 445-450
[4]
M. Bruna Esteban, Ortíz Escandell MÁ, P. Parilla Paricio.
Cancer of the esophagogastric junction: A border in continuous movement.
Cir Esp (Engl Ed)., 97 (2019), pp. 425-426
[5]
X. Li, S. Gong, T. Lu, et al.
Proximal Gastrectomy Versus Total Gastrectomy for Siewert II/III Adenocarcinoma of the Gastroesophageal Junction: a Systematic Review and Meta-analysis.
J Gastrointest Surg., 26 (2022), pp. 1321-1335
[6]
S. Blank, T. Schmidt, P. Heger, et al.
Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?.
Gastric Cancer., 21 (2018), pp. 303-314
[7]
S. Agarwal, M.G. Bell, L. Dhaliwal, et al.
Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Dig Dis Sci., 69 (2024), pp. 246-253
[8]
K. Matsuno, R. Ishihara, M. Ohmori, et al.
Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
J Gastroenterol., 54 (2019), pp. 784-791
[9]
A. Tang, D. Sohal, M. McNamara, S.C. Murthy, S. Raja.
Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination.
Surg Oncol Clin N Am., 29 (2020), pp. 647-653
[10]
A. Di Leo, A. Zanoni.
Siewert III adenocarcinoma: treatment update.
Updates Surg., 69 (2017), pp. 319-325
[11]
D. Ruiz de Angulo Martín.
The art of making decisions in surgical oncology.
Cir Esp (Engl Ed)., 101 (2023), pp. 503-504
[12]
V. Von Hacker.
Uber Oesophagoplastik in Allgemeinen und über den Ersatz der Speiseröhre durch antethorakle Haut-Dickdarmschlauchbildung im besonderen.
Arch Klin Chir, 105 (1914), pp. 973-1018
[13]
V. Reslinger, H. Tranchart, E. D’Annunzio, et al.
Esophageal reconstruction by colon interposition after esophagectomy for cancer analysis of current indications, operative outcomes, and long-term survival.
J Surg Oncol., 113 (2016), pp. 159-164
[14]
M.V. Sanchez, E.T. Alicuben, J.D. Luketich, I.S. Sarkaria.
Colon Interposition for Esophageal Cancer.
Thorac Surg Clin., 32 (2022), pp. 511-527
[15]
J. Wang, Y. Liang, A. Xue, et al.
Intratumoral CXCL13+ CD160+ CD8+ T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer.
J Immunother Cancer., 12 (2024),
